- Industry
- Pharmaceuticals
- Sector
- Healthcare
- Employees
- 1600
- Equity Type
- ORD
- Address
- Leamington,N8H 5L4 Canada
- Phone
- 844-845-7291
- Fax
- -
Name
|
Age
|
Since
|
Title
|
---|---|---|---|
Jodi Lynn Heimpel Butts | 50 | 2019 | Independent Director |
Thomas P. Looney | 59 | 2018 | Independent Director |
John M. Herhalt | 65 | 2018 | Independent Director |
Irwin David Simon | 65 | 2018 | President, CEO & Chairman |
Joschka Fischer | 75 | 2021 | Member of International Advisory Board |
Jaime Gama | 0 | 2021 | Member of International Advisory Board |
David G. Hopkinson | 51 | 2019 | Independent Director |
Gerard Araud | 68 | 2021 | Member of International Advisory Board |
Alexander John Gosse Downer | 71 | 2021 | Member of International Advisory Board |
Michael S. Steele | 65 | 2021 | Member of International Advisory Board |
Lorna R. Marsden | 81 | 2021 | Member of International Advisory Board |
David F. Clanachan | 61 | 2021 | Independent Director |
Donald McKinnon | 0 | 2021 | Member of International Advisory Board |
James C. O'Brien | 0 | 2021 | Member of International Advisory Board |
Renah A. Persofsky | 65 | 2017 | Independent Vice Chairman & Lead Director |
Lloyd Axworthy | 83 | 2021 | Member of International Advisory Board |
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.